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Abstract
It is becoming increasingly apparent that not all insulin-secreting beta cells are equal. 
Subtle differences exist at the transcriptomic and protein expression levels, with 
repercussions for beta cell survival/proliferation, calcium signalling and insulin release. 
Notably, beta cell heterogeneity displays plasticity during development, metabolic stress 
and type 2 diabetes mellitus (T2DM). Thus, heterogeneity or lack thereof may be an 
important contributor to beta cell failure during T2DM in both rodents and humans. The 
present review will discuss the molecular and cellular features of beta cell heterogeneity 
at both the single-cell and islet level, explore how this influences islet function and 
insulin release and look into the alterations that may occur during obesity and T2DM.
Introduction
Type 2 diabetes mellitus (T2DM) is a complex metabolic 
disorder which occurs when genetically susceptible 
individuals are exposed to a permissive environment. It 
currently affects ~10% of the adult population (Ezzati 
& World Health O 2004) and represents an escalating 
healthcare crisis. T2DM not only shortens lifespan and 
decreases quality of life, but also consumes healthcare 
budgets, with global costs approaching £825 billion per 
year (2016). During the early stages of T2DM, peripheral 
(and possibly central (Kullmann et  al. 2016)) insulin 
resistance is compensated by an increase in insulin 
secretion from the beta cell mass, maintaining glucose 
homeostasis (Samuel & Shulman 2012). However, at a 
poorly defined point in time, beta cells are pushed over 
the functional precipice, resulting in relative insulin 
insufficiency and a large ramp-up in circulating glucose 
concentration (Halban et  al. 2014). Together with 
dyslipidaemia, hyperglycaemia drives the wide-ranging 
sequelae of T2DM including retinopathy, neuropathy, 
vasculopathy, renal and cardiovascular disease and 
increased risk of developing cancer (Forbes & Cooper 
2013). In addition to diet and exercise, T2DM treatment 
relies on the lifelong use of oral anti-diabetic agents, 
which boost insulin release, improve insulin action or 
increase renal glucose excretion (Fowler 2007). However, 
a significant number of patients will eventually transition 
to exogenous insulin injection, probably reflecting the 
loss of any residual beta cell function (Home et al. 2014).
While current T2DM treatment aims to preserve 
endogenous insulin release for as long as possible, 
prevention of beta cell failure remains an important 
goal. The mechanisms through which single beta cells 
fail are well defined, at least in rodents, and encompass 
loss of glucose responsiveness, de-differentiation, 
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ER stress and apoptosis, all probably secondary to a 
combination of glucolipotoxicity and cytotoxicity (Porte 
& Kahn 2001, Prentki & Nolan 2006). Maintenance of 
insulin release during T2DM therefore requires better 
understanding of the mechanisms underlying beta cell 
proliferation and function in adults, with the hope that 
these can be harnessed or maintained to restore insulin 
secretion. Recent studies have opened up new avenues 
in our investigation of beta cell failure and insulin 
secretion, by showing the existence of subtle molecular 
and cellular differences between beta cells which give 
rise to proliferative and functional subpopulations 
(Gutierrez et al. 2017). This ‘heterogeneity’ or ‘diversity’ 
is driven partly by the organisation of beta cells into islet 
microorgans (Benninger & Piston 2014) and is unlikely 
to be properly appreciated by current models of beta 
cell failure. Importantly, beta cell subpopulations may 
contribute to development and proliferation of other 
beta cells, as well as play an exaggerated role in insulin 
secretion (Roscioni et  al. 2016, Avrahami et  al. 2017, 
Carrano et  al. 2017). Thus, beta cell heterogeneity or 
diversity should be an important consideration when 
attempting to understand T2DM pathogenesis, since 
subpopulations may be differentially targeted by insults 
or treatments. Conversely, islet-like structures engineered 
from induced pluripotent stem cells for transplantation, 
and even genome editing, may need to take into account 
beta cell heterogeneity.
The present review will discuss the influence of beta 
cell heterogeneity on islet function and insulin release, 
and its relevance for T2DM. Particular attention will 
be paid to recent single-cell studies describing some of 
the molecular and cellular underpinnings of beta cell 
heterogeneity. We will also focus on the role of the 
islet context in giving rise to beta cell heterogeneity by 
discussing in situ and in vivo imaging studies. Finally, new 
technologies available for the precise interrogation of beta 
cell heterogeneity will be described, before highlighting 
future challenges for the field, including translation of 
results to the clinic.
Stimulus–secretion coupling in single 
beta cells
Beta cells are well adapted as glucose sensors. Due to 
expression of low-affinity glucose transporters (GLUT1 
in humans, GLUT2 in rodents) and glucokinase (German 
1993, De Vos et al. 1995), beta cells only respond to elevated 
glucose, avoiding the inappropriate and damaging release 
of insulin. Following transport into the cytosol, the sugar 
stimulates oxidative and glycolytic metabolism, leading 
to ATP generation in the mitochondria at the expense 
of other pathways (e.g. pentose phosphate shunt). The 
ensuing increase in cytosolic ATP/ADP ratio closes ATP-
sensitive K+ (KATP) channels, reducing K+ efflux through the 
Kir6.2 pore and depolarising the membrane (Ashcroft et al. 
1984). Together with Na+ conductance, this drives action 
potential firing and the opening of voltage-dependent 
Ca2+ channels (VDCC): primarily L-type in rodents but 
T-, P/Q- and L-type in humans (Rorsman & Braun 2013, 
Rutter & Hodson 2013). The increased cytosolic Ca2+ 
fluxes interact with small N-ethylmaleimide-sensitive 
factor receptor proteins such as vesicle-associated 
membrane protein, synaptosomal-associated protein 
of 25 kDa (SNAP25) and syntaxin (Wheeler et  al. 1996, 
Kwan & Gaisano 2009), stimulating insulin granule 
translocation to the membrane, granule fusion and 
dissolution of insulin crystals into the circulation. Insulin 
secretion is further assisted by ‘amplifying’ pathways 
(e.g. cAMP), which are KATP channel independent but 
beta cell metabolism-dependent (Henquin 2000). 
Indeed, molecules such as hormones, neurotransmitters, 
nucleotides, amino acids and lipids are all able to strongly 
influence insulin secretion by either acting as nutrients 
or through interactions with receptors/ion channels. 
Perhaps the best characterised signals are derived from the 
incretin hormones glucagon-like peptide-1 (GLP-1) and 
glucose-dependent insulinotropic peptide (GIP) released 
from the enteroendocrine L-cells and K-cells, respectively, 
following food intake and bile acid transit (Diakogiannaki 
et al. 2012, Parker et al. 2012). GIP and GLP-1 bind to their 
cognate G-protein-coupled receptors (GPCRs) on beta 
cells, stimulating adenylate cyclase activity and cAMP 
generation, activation of PKA and Epac, as well as ERK and 
beta arrestins (Baggio & Drucker 2007, Leech et al. 2011, 
Campbell & Drucker 2013). Through interactions with 
VDCC and the exocytotic machinery (MacDonald et  al. 
2002, Gromada et  al. 2004, Leech et  al. 2011), GIP and 
GLP-1 boost insulin secretion (so-called ‘incretin effect’), 
largely accounting for the extra portion of the hormone 
secreted in response to oral vs intravenous glucose (Nauck 
et al. 1986, Nauck & Meier 2016). Since GIP receptors are 
downregulated/desensitised during obesity/T2DM (Lynn 
et  al. 2001, Meier & Nauck 2010), stabilised variants of 
GLP-1 have served as a template for production of incretin 
mimetics. For an in-depth review of stimulus–secretion 
coupling in the beta cell, the reader is referred to (Rutter 
et al. 2015).
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Single-cell studies of beta cell heterogeneity
The concept of heterogeneity is not new. Differences 
in insulin release (Salomon & Meda 1986), glucose 
metabolism (Kiekens et  al. 1992), glucokinase (Jetton & 
Magnuson 1992), insulin expression (Schuit et al. 1988), 
membrane potential (Dean & Matthews 1968) and Ca2+ 
(Zhang et al. 2003, Kenty & Melton 2015), cAMP (Dyachok 
et al. 2006) and NAD(P)H (Piston et al. 1999) signals have 
all been described in beta cells. However, it is only over 
the past decade that advances in imaging, genomics and 
proteomics have allowed a more detailed snapshot of the 
molecular and cellular drivers of beta cell heterogeneity. A 
spate of single-cell screening studies (See 1 in Table 1) in 
mouse and human islets have segregated out a number of 
beta cell subpopulations according to their transcriptomic 
profile, for example, due to differing abundances of 
genes for ER/oxidative stress (Baron et  al. 2016, Muraro 
et al. 2016), and in the process have provided useful beta 
cell ‘atlases’ (see Supplementary methods for a summary 
of single-cell screening methodology, as well as the 
section on supplementary data given at the end of this 
article). However, relatively few studies have investigated 
subpopulation plasticity and its potential to influence 
disease or islet function. Using marker analysis coupled 
with single-cell RNA sequencing (scRNA-seq), Dorrell 
et  al. were able to show the existence of four distinct 
human beta cell subpopulations (β1–4), based upon 
differing expression of ST8SIA1 and CD9. Notably, the 
ST8SIA1-positive β3 and β4 populations exhibited lower 
insulin release during T2DM (Dorrell et al. 2016). At the 
protein level, high-throughput analyses of human beta 
cells immunostained with metal-labelled antibodies and 
subjected to time-of-flight mass cytometry (CyTOF) (See 2 
in Table 1) showed three states: C1, C2 and C3 (Wang et al. 
2016a). The C1 state – shown to be PDX1high/Inshigh and 
poorly proliferative – was plastic depending on age and 
obesity, and increased in incidence with time (Wang et al. 
2016a). This suggests that, during ageing and metabolic 
stress, there is a shift from a proliferative to a more mature 
beta cell phenotype, which may partly explain the limited 
capacity to regenerate beta cells in the adult, as well as 
their eventual failure under chronic metabolic burden.
Analysis of cell surface markers revealed that the 
Wnt/planar polarity effector, Fltp or Flattop, demarcates 
proliferative and mature beta cells (Bader et  al. 2016). 
Fltp+ beta cells are more mature, with improved insulin 
secretion and mitochondrial function, whereas the Fltp− 
beta cell subpopulation expands during metabolic stress, 
displaying increased proliferation. Thus, an increase in 
the ratio of Fltp−/Fltp+ cells may be expected to promote/
maintain beta cell mass during T2DM, but would be 
expected to compromise insulin release due to their 
relatively poor glucose responsiveness. Along similar lines, 
Van der Meulen et al. identified a rare (~2% proportion) 
subpopulation of beta cells, characterised by the absence 
of urocortin 3 (Ucn3) expression, which represent an 
intermediate stage during the transdifferentiation of alpha 
to beta cells, thus acting as a ‘neogenic niche’ (van der 
Meulen et al. 2017). Ucn3− cells were metabolically naive 
(i.e. low glucokinase and oxidative phosphorylation) and 
were unable to properly sense glucose or support Ca2+ 
fluxes in response to glucose (van der Meulen et al. 2017), 
supporting previous observations that functional beta cell 
maturation is associated with increased Ucn3 expression 
(Blum et al. 2012). See Table 2 for a summary of selected 
beta cell subpopulations involved in islet plasticity 
and insulin release. The reader is referred to (Roscioni 
et  al. 2016, Avrahami et  al. 2017, Carrano et  al. 2017, 
Gutierrez et al. 2017) for more comprehensive reviews of 
subpopulations identified to date.
Together, high-throughput scRNA-seq, CyTOF or 
reporter studies have provided unexpected insights 
into beta cell heterogeneity, identifying a number of 
subpopulations that display high degree of plasticity. The 
binary nature of these subpopulations appears to be a 
common trait: subgroups with two broad characteristics 
predominate during metabolic stress and ageing. Beta cells 
with decreased maturity, glucose sensing, metabolism and 
insulin secretion increase in proportion during metabolic 
stress, which may reduce islet function at the expense of 
maintaining beta cell renewal. Nevertheless, this may be 
balanced by expansion of beta cells with increased maturity 
and insulin expression, but poorer proliferative capacity. 
Whether these phenotypic shifts are interdependent is 
not known, but this raises the tantalising prospect that 
the islet is geared toward preserving heterogeneity and 
that eventual loss of this (i.e. as a subpopulation begins to 
predominate) is a key trigger for insulin secretory failure.
There are a number of caveats that need to be 
carefully considered when interpreting transcriptomic 
and biomarker-based studies. RNA-seq is limited in its 
coverage of the genome, with ~10% genes being missed 
even at high read numbers (Anisimova et al. 2015). While 
CyTOF resolution is excellent compared to conventional 
fluorescence-activated cell sorting (FACS) (Giesen et  al. 
2014), the poor availability of metal-labelled antibodies 
for many markers means that screening is still limited/
partially biased, although this is expected to improve 
with labelling kits. In marker-based studies, reporter 
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Table 1 Summary of technologies available for interrogating beta cell heterogeneity.
Technology Advantages Disadvantages Reference
RNA-seq (1) Ozsolak & Milos (2011)
• Transcriptome-wide coverage
• Sensitive – requires ng of 
DNA
• Islet dissociation required
• Cells with upregulated stress pathways 
generally excluded from analysis
• Still expensive
• Biological and technical variability due 
to (1) loss of transcripts during RNA 
isolation or (2) transcript coverage
CyTOF (2) Proserpio & Lönnberg 
(2016)
• Parallel screening of up to 
40 markers
• Three orders of magnitude 
between detection channels
• Excellent discrimination 
of negative and positive 
populations
• Good discrimination of high-
low-negative populations
• Islet dissociation required
• Expensive machinery required
• Antibody panels available, but limited 
selection for metabolism
• Antibodies need to be labelled in 
house if not available
• General lack of reliable antibodies for 
some beta cell proteins/markers
Optogenetics (3) Johnston et al. (2016)
• Conditionally targeted
• Well characterised
• Spectral variants
• Stimulatory or inhibitory 
variants
• Presence of a non-mammalian 
channel/pump may affect cell function
• Protein overexpression may interfere 
with cell function
• Limited use in human tissue
Photopharmacology (4) Broichhagen et al. 
(2015c)
• Usually based on known 
drugs/molecules
• No need for genetic 
introduction
• Exogenously applied
• Can be spectrally-tuned
• Useful in human tissue
• Not conditional
• Non-binary response (i.e. generally 
some activity)
• Can undergo metabolism depending 
on molecule
• Subject to normal pharmacokinetics/
pharmacodynamics
• UV light is required for 
photoswitching of the majority of 
available compounds
Tethered pharmacology (5) Podewin et al. (2018)
• Usually based on known 
drugs/molecules
• Conditionally targeted 
using enzyme self-labels 
or engineered cysteine 
residues.
• Can be combined with 
photopharmacology to make 
tethered photoswitches
• Use in human and mouse primary 
tissue requires viral vectors
• Protein overexpression may interfere 
with cell function
Single-cell metabolomics (6) Aerts et al. (2014), 
Ibanez et al. (2013)
• Dynamic snapshot of cell 
metabolism
• Can be performed in the 
intact tissue setting
• Slow throughput compared to CyTOF 
and RNA-seq
• Sensitivity still relatively poor 
compared to conventional 
metabolomics
Transcriptome in vivo 
analysis (7)
Lovatt et al. (2014)
• Can be performed in the 
intact tissue
• Requires cell-penetrating peptides to 
introduce the TIVA-tag
• Slow throughput
In vivo imaging (8) Speier et al. (2008b)
 
 
 
• Allows investigation of beta 
cell function with preserved 
blood and neural supplies 
• Technically challenging
• Needs expensive microscopy 
equipment
• Slow throughput
 
 
 
The numbers in brackets indicate position in the main body of the manuscript.
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constructs may not faithfully report protein expression, 
and in many cases, display limited changes in expression 
vs the protein under examination. Furthermore, how the 
subpopulations described to date co-exist together in the 
islet is not well understood, and this may be complicated 
by the relative dynamics of subpopulation plasticity. So 
far, most studies report results obtained at a specific time 
point (e.g. neonatal, postnatal and adult), without taking 
into account the changes that may appear in-between 
the time of assessment. Lastly, following dissociation 
from the islet, beta cells may lose many characteristics 
endowed through cell–cell contacts/signalling, certain 
stress pathways may be upregulated and a study may be 
skewed toward subpopulations that are more robust (hint: 
some are fragile, see below).
Functional beta cell heterogeneity in the 
intact islet
In response to glucose, beta cells display intense Ca2+ 
oscillations, which are not completely synchronous but 
well-coordinated throughout the syncytium (Benninger 
et  al. 2008, Stozer et  al. 2013). By contrast, beta cells 
cultured in two dimensions mount much more stochastic 
responses to secretagogues, release less insulin per capita and 
possess decreased insulin biosynthetic capacity (Lernmark 
1974, Hodson et al. 2013). This diminished functionality 
develops as a result of the loss of three-dimensional 
electrical communications through gap junctions 
following islet dissociation. Indeed, gap junctions couple 
on average 6–7 neighbouring beta cells, with a speed of 
electrical exchanges of ~13.5 ms, commensurate with 
the transmission of Ca2+ signals (~80 µm/s) (Aslanidi 
et  al. 2001, Benninger et  al. 2008, Zhang et  al. 2008, 
Stozer et al. 2013). Studies using islets from mice globally 
or conditionally deleted for the gap junction protein 
connexin 36 (Cx36; encoded by Gjd2) – the major isoform 
expressed in beta cells (Serre-Beinier et al. 2000) – showed 
loss of coordinated responses to glucose, which resembled 
those observed in dissociated beta cells (Ravier et  al. 
2005, Head et al. 2012). Other plausible mechanisms for 
beta cell–beta cell communications include diffusion of 
Table 2 Selected beta cell subpopulations involved in islet plasticity and insulin release.
Subpopulation Features Plasticity Reference
ST8SIA1− GLUT2+++ ↓ T2DM Dorrell et al. (2016)
Insulin+++
Maturity+++
ST8SIA1+ GLUT2+ ↑ T2DM Dorrell et al. (2016)
Insulin+
Maturity+
C1 Insulin+++ ↑ Ageing Wang et al. (2016a)
Maturity+++ ↓ Obesity
Fltp+ Metabolism+++ ↓ Metabolic stress Bader et al. (2016)
Insulin+++
Maturity+++ ↓ Metabolic stress
Proliferation+
Fltp− Metabolism+ ↑ Metabolic stress Bader et al. (2016)
Insulin+
Maturity+ ↑ Metabolic stress
Proliferation+++
Ucn3− Metabolism+ ↑ Metabolic stress van der Meulen et al. (2017)
Ca2++
Maturity+
Transdifferentiation+++
Hub (eNpHR3.0) Metabolism+++ ↓ Metabolic stress Johnston et al. (2016)
Ca2++++
Insulin++
Maturity++
ChR2 Metabolism+++ ↓ Metabolic stress Westacott et al. (2017b) 
Ca2++++
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chemical messengers (i.e. paracrine signalling) (Squires 
et al. 2002, Yang et al. 2011), contact-dependent signalling 
(i.e. ephrin) (Konstantinova et al. 2007) and ciliary (Gerdes 
et al. 2014) signalling, although the contribution of these 
slower communication modalities to islet function is less 
well characterised (reviewed in Rutter & Hodson 2014).
While human beta cells respond to glucose more 
stochastically (Martin & Soria 1996, Cabrera et al. 2006), 
regional coordination is detected between defined clusters 
(Cabrera et  al. 2006, Westacott et  al. 2017a), probably 
reflecting the differing architecture of islets in humans, 
where beta cell–beta cell interactions and gap junction 
signalling are constrained by an extra folding step during 
development (Bosco et  al. 2010, Steiner et  al. 2010). 
Human beta cells appear to be more dependent on the 
gut-derived peptide GLP-1 for coordinated responses. 
Incretin application induces large and synchronous Ca2+ 
rises that are lost following shRNA-mediated knockdown 
of GJD2 or islet dissociation (Hodson et  al. 2013). We 
speculate that the greater dependency on incretin input 
for coordination between human beta cells may reflect a 
mechanism to tightly entrain insulin release to mealtime, 
as GLP-1 is released from enteroendocrine L-cells following 
food ingestion (Diakogiannaki et  al. 2012). By contrast, 
rodents graze during the dark phase, and in this scenario, 
glucose may provide adequate entrainment of insulin 
release with food intake. Further studies should look into 
the role of the enteroinsular axis in beta cell connectivity 
both in humans and rodents.
Coordinated beta cell–beta cell behaviour appears 
to be important for normal islet function and insulin 
release. Mice lacking Gjd2/Cx36 show lowered indices of 
coordinated beta cell Ca2+ activity and loss of pulsatile 
insulin secretion both in vitro (Ravier et al. 2005) and in 
vivo (Head et  al. 2012), leading to glucose intolerance 
despite preserved steady-state insulin release (Ravier 
et al. 2005, Head et al. 2012). Similarly, beta cell–beta cell 
coordination may be relevant for islet failure during T2DM. 
The beta cell population in islets from genetically obese 
ob/ob mice displays poorly organised responses to glucose 
with loss of pulsatile insulin release (Ravier et al. 2002), 
and Cx36 expression and gap junction coupling strength 
between beta cells is markedly reduced by exposure to 
a pro-inflammatory cytokine cocktail (Farnsworth et  al. 
2015, Johnston et al. 2016). In human islets, coordinated 
beta cell responses to GLP-1 are inversely correlated with 
donor BMI and are lost following incubation with excess 
fatty acids, possibly due to a reduction in Cx36 expression 
(Hodson et al. 2013) (Fig. 1A, B and C). A decline in beta 
cell coordination and gap junction coupling was also 
associated with defective insulin secretory dynamics in 
islets from older donors (Westacott et  al. 2017a). Lastly, 
knockdown of ADCY5 and Tcf7l2, genes identified 
by GWAS as potentially harbouring single nucleotide 
polymorphisms (SNPs) increasing T2DM risk, led to 
marked decreases in beta cell–beta cell coordination 
(Hodson et  al. 2014, Mitchell et  al. 2014), as well as 
impaired glucose- and GLP-1-stimulated insulin secretion. 
Thus, loss of proper gap junction coupling and coordinated 
beta cell responses to secretagogues, may lead to impaired 
insulin release under conditions associated with T2DM 
(i.e. obesity, inflammation and gene silencing). For a 
comprehensive review of heterogeneity in the islet, see 
(Benninger & Piston 2014).
Beta cell heterogeneity and insulin secretion
Differences in insulin secretion between individual beta 
cells were originally described using haemolytic plaque 
assay, including plasticity in response to pregnancy 
(Salomon & Meda 1986, Hiriart & Ramirez-Medeles 1991, 
Maedler et al. 2006). Subsequent studies using total internal 
refraction microscopy (TIRF-M) reported heterogeneity in 
secretory vesicle behaviour in rodent and human beta 
cells, including kiss-and-run exocytosis where fusion with 
the membrane occurs transiently, facilitating vesicle reuse 
(Tsuboi & Rutter 2003, MacDonald et al. 2006, Rutter & 
Hill 2006, Hanna et  al. 2009), as well as differences in 
submembrane granule turnover and motility depending 
on stimulus and granule age (Hoboth et al. 2015, Bruning 
et al. 2017). However, TIRF-M only encompasses a dozen or 
so beta cells (Li et al. 2013), limiting the study of secretory 
heterogeneity across the entire islet. Nearly 20 years later, 
the advent of two-photon imaging enabled the tracking 
of the granule fusion with the beta cell membrane 
at nanometer axial resolution. Pioneering studies by 
Takahashi et al. deployed two-photon extracellular polar 
tracer imaging-based quantification (TEPIQ) to report 
uptake of the polar tracer, sulforhodamine B, into granules 
following fusion with the membrane, allowing exocytosis 
to be tracked via the appearance of fluorescent spots 
(Takahashi et al. 2002). Almost 60% of the beta cells were 
found to be involved in exocytosis, with the majority of 
events occurring toward the interstitial or non-vascular 
compartment. Interestingly, kiss-and-run exocytosis 
in the intact islet setting is an exceedingly rare event, 
suggesting heterogeneity is strongly shaped by cell–cell 
interactions (and possibly extracellular matrix content) 
(Takahashi et  al. 2002, Ma et  al. 2004). However, some 
polarity in insulin release was detected in intact islets, with 
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exocytosis preferentially toward the vessels surrounded 
by beta cell rosettes (Takahashi et  al. 2002). Similar 
TEPIQ studies showed that glucose recruits single cells 
throughout the islet to exocytosis, increases the number 
of fusion events per beta cell and induces coordinated 
oscillatory exocytotic activity, reminiscent of Ca2+ signals 
(Low et al. 2013) (Fig. 1D). The same group showed that, 
when viewed in three dimensions, insulin secretion is 
asymmetric and targeted toward the vasculature (Fig. 1D), 
probably due to enrichment of liprin, piccolo and Rab2-
interacting molecule at the vascular face (Low et al. 2014). 
Notably, beta cells in islets from glucose intolerant db/db 
mice showed some loss of insulin secretory heterogeneity, 
with 73% of cells becoming refractory to stimulation (Fig. 
1D), although polarisation toward the vasculature was not 
studied  (Do et al. 2014). In human islets, granule release 
Figure 1
Beta cell communication and insulin 
release: (A) Gap junctions comprising 
connexin 36 allow beta cells to 
coordinate their activities within the 
intact islet. Gap junction signalling is 
reduced during obesity and ageing, as 
well as in individuals harbouring risk 
alleles for T2DM (SNP). (B) Beta cells in 
human islet mount coordinated 
responses to incretins such as 
glucagon-like peptide 1 (GLP-1), 
facilitating insulin release. (C) During 
obesity, a reduction in gap junction 
signalling leads to loss of coordinated 
beta cell activity, impairing GLP-1-
stimulated insulin secretion. (D) Insulin 
secretion is polarised toward the 
vasculature and in rodent models of 
obesity and T2DM, a reduction in the 
number of actively secreting beta cells 
is detected. In humans, some beta cells 
and beta cell clusters contribute to 
insulin secretion more than others. (E) 
Islets display a large functional reserve, 
with only a handful of first responders 
supporting glucose-stimulated insulin 
secretion. Figures were adapted from 
Servier Medical Art under a CC-BY3.0 
licence (https://creativecommons.org/
licenses/by/3.0/).
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was shown to be pulsatile/oscillatory, with coordination 
detected only between beta cell clusters. The difference 
in coordination reflects the compartmentalisation of the 
Ca2+ response in this species, which could mirror the 
arrangement of beta cells vs alpha cells (Cabrera et  al. 
2006, Almaca et  al. 2015). In contrast to the mouse, a 
minority of beta cells contribute the majority of insulin 
secretion in humans, as assessed using haemolytic plaque 
assays (Wojtusciszyn et al. 2008) (Fig. 1D), although this 
may imply a prolonged secretion where secretory events 
tend to become more localised (Almaca et al. 2015). How 
heterogeneity in insulin secretion changes during T2DM 
is not well understood, probably due to difficulties in 
obtaining fresh tissue from donors. However, studies 
using matrix-assisted laser desorption ionisation (MALDI) 
imaging in fixed tissue, together with in vitro experiments, 
demonstrated that stearoylcarnitine accumulated in beta 
cells to arrest insulin synthesis, while acetylcarnitine and 
N-acyl taurines increased insulin secretion to induce beta 
cell failure (Aichler et al. 2017).
By contrast to in vitro experiments, technically 
demanding live imaging of the pancreatic surface in 
anaesthetised animals revealed that only a fraction 
of islets responded to acute glucose administration 
(Fig. 1E). This was characterised by rapid dispossession of 
insulin, transgenically marked using C-peptide–bearing 
superfolder GFP (Zhu et al. 2016). While the contribution 
of individual beta cells was likely not determined at the 
resolutions employed in these studies, it is nonetheless 
intriguing that most islets are unresponsive, suggestive 
of a functional reserve and tertiary level of heterogeneity 
(Zhu et al. 2016). Thus, significant heterogeneity in insulin 
secretion exists in vitro, with recruitment, coordination 
and polarisation toward the vasculature, with species 
differences appearing to reflect Ca2+ patterning. Further 
studies are required to understand how this is sculpted 
in vivo, where neural and vascular supplies may also 
influence beta cell function, as well as the fate of secreted 
insulin depending on the metabolic status (Michau et al. 
2015).
Functionally interrogating beta cell 
heterogeneity in situ
Although coordinated, Ca2+ responses to glucose vary in 
space and time within the beta cell compartment. Some 
islet sub-regions respond early to stimulus (Stozer et  al. 
2013), with Ca2+ responses propagating as gap junction-
dependent waves across the islet (Benninger et al. 2008, 
2014), indicating a presence of so-called pacemakers 
(Ämmälä et al. 1991, Squires et al. 2002, Benninger et al. 
2014). Thus, beta cell–beta cell communication and Ca2+ 
signalling in situ are clearly heterogeneous. Optogenetics 
(See 3 in Table  1) allied to high-speed imaging has 
recently opened up the possibility to precisely interrogate 
the influence of beta cell heterogeneity directly in the 
intact islet, where endocrine cell interactions critical for 
proper insulin release are preserved. Studies by Reinbothe 
et al. and Kushibiki et al. employed channel rhodopsin 2 
(ChR2), a light-activated Na+ channel, to optically control 
insulin release from beta cells in vitro, as well as in vivo 
in mice rendered diabetic with streptozotocin (Reinbothe 
et al. 2014, Kushibiki et al. 2015). Subsequent studies by 
our lab using the yellow/orange light-activated Cl− pump 
halorhodopsin 3.0 (NpHR3.0) to pinpoint silence cell 
activity revealed that a minority of beta cells, termed 
hubs, are tasked with orchestrating islet-wide Ca2+ and 
insulin secretory responses to glucose (Johnston et  al. 
2016) (Fig. 2A and C). These beta cells constitute ~1–10% 
of the population at the islet surface, display activity 
profiles that precede and lead those of the rest of the 
population (i.e. pacemaker-like) and tend to host the 
majority of coordinated activity (think: network servers 
or major airports). To support their activity, hubs possess 
high levels of glucokinase and highly hyperpolarised 
mitochondria, indicative of increased ATP synthase 
activity and ATP generation. Unexpectedly, this was 
associated with lowered but not absent Pdx1 and Nkx6.1 
and reduced insulin expression, resembling cells identified 
using RNA-seq (GKhigh/Pdx1low/Nkx6.1low) (Xin et al. 2016) 
and gene reporters (Pdx1+/insulinlow) (Szabat et al. 2009), 
and suggestive of a relatively immature phenotype.
How does metabolic adaptation in hubs fit with the 
apparent loss of beta cell identity, given that the later 
supposedly endows the former? Maturity, as defined by 
expression of transcription factors such as Nkx6.1, Pdx1 
and MafA may not always be obligatory for glucose 
metabolism. For example, NAD(P)H responses in beta 
cells deficient in MafA are almost normal (Hang et  al. 
2014) and deletion of a single Pdx1 allele in beta cells 
increased apoptosis, but did not affect Ca2+ fluxes, 
Ca2+ conductance, glucose sensing or insulin secretion 
in vitro (Johnson et  al. 2003). In addition, hubs may 
represent an immature and proliferative subpopulation 
in adults, similar to Ucn3− cells (van der Meulen et  al. 
2017), although differentiated by their normal glucose 
responsiveness, heightened mitochondrial metabolism 
and improved Ca2+ fluxes. Indeed, replicating beta cells 
double RNA abundance of the majority of genes, except 
for those involved in key beta cell functions such as 
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secretion (Klochendler et  al. 2016). During postnatal 
development, immature proliferative cells possess 
high expression levels of amino acid metabolism and 
mitochondrial genes (Zeng et  al. 2017). Nonetheless, 
hubs were susceptible to failure following introduction of 
a pro-inflammatory milieu, which may reflect a relative 
lack of Pdx1 and SERCA2, the former interacting with 
the latter to maintain organellar Ca2+ homeostasis and 
protect against ER stress (Sachdeva et al. 2009, Johnson 
et al. 2014).
Using ChR2, Westcott et  al. activated single beta 
cells at random and calculated the proportion of the 
islet showing corresponding Ca2+ elevations (Westacott 
et  al. 2017b). While these elevations were restricted to 
closest neighbours in most experiments, in ~5% of trials 
Ca2+ spread over large islet regions. Suggesting metabolic 
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Figure 2
Beta cell heterogeneity and islet function. (A) Optogenetic silencing of less mature and metabolically-adapted beta cells, termed hubs, leads to a loss of 
coordinated population activity (eNpHR3.0; halorhodopsin3.0, a yellow light-activated Cl− pump). (B) Optogenetic activation of cells with high but not 
low NAD(P)H levels leads to activation across the islet (ChR2, channel rhodopsin 2, a blue light-activated Na+ channel). (C) Insulin secretion is impaired 
following silencing of hubs, but not other single beta cells. (D) Hubs are targeted by cytokines to mimic the pro-inflammatory milieu associated with 
T2DM. (E) Hubs are stable for a few hours, but their fate is not known over longer time periods. Possibilities include: (1) remaining a hub; (2) becoming 
a non-hub beta cell or (3) transdifferentiation into another cell type. Figures were adapted from Servier Medical Art under a CC-BY3.0 licence (https://
creativecommons.org/licenses/by/3.0/).
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adaptation in these cases, the Ca2+ elevation was associated 
with cells/sub-regions displaying the highest NAD(P)
H responses (Westacott et  al. 2017b; Fig. 2B). However, 
the same authors showed that areas with low NAD(P)
H and high Ca2+ oscillation frequency were associated 
with the origin of Ca2+ wave initiation. Whether these 
optogenetically defined beta cell subpopulations are 
distinct, or are overlapping but arise as a consequence of 
the wave propagation/correlation analysis used, needs to 
be further investigated. These studies together show that 
beta cell subpopulations in situ can play a disproportionate 
role in dictating islet responses to glucose, that this may be 
due to alterations in metabolism, and that these cells may 
fail in response to diabetes-like insults (Fig. 2A-E). It will 
be interesting to determine if these subpopulations have 
a similar protein barcode to hubs or other identified beta 
cell subpopulations that display metabolic adaptation.
Whether or not optogenetically defined beta cell 
subpopulations are stable or dynamic is difficult to 
assess due to restrictions on recording time in vitro (a few 
hours at most; Fig. 2E). Modelling studies have shown 
that pacemaker regions may stem from areas of highest 
excitability (Benninger et al. 2014), and this may change 
depending on ion channel expression levels (turnover 
times for Kir6.1/SUR1 complexes are estimated to be 
~2.2 h) (Crane & Aguilar-Bryan 2004) or proximity to 
non-beta cells (such as delta cells, shown to convey beta 
cell-driven alpha cell suppression) (Briant et  al. 2017)). 
Moreover, how activity of single beta cells and small 
sub-regions can lead to Ca2+ signal propagation across 
large regions of the islet is not known. Presumably, gap 
junctions play a role, since their knockdown decreases the 
distance over which signals travel (Johnston et al. 2016) 
and disrupts beta cell–beta cell coordination (Ravier et al. 
2005, Head et al. 2012). Other explanations may lie outside 
of the field of view, since most experiments only consider 
the top couple of islet layers. While 3D imaging of mouse 
islets is challenging due to the highly scattering nature 
of endocrine cells densely packed with secretory granules, 
studies in the more transparent zebrafish model using 
light sheet microscopy are likely to be more informative 
(Singh et al. 2017).
As a technology for interrogation of beta cell 
function, optogenetics is not without drawbacks. First, 
high (and potentially phototoxic) laser powers are 
required to activate ChR2 and especially eNpHR3.0, 
and constant light exposure can ground-deplete their 
activity cycle (i.e. render them refractory). Second, Cl− 
and H+ pumps required for cell silencing can generate 
profound hyperpolarisation, similar to full KATP channel 
opening, with yet unknown consequences on long-term 
beta cell function. The mechanisms occurring in beta 
cells likely involve transcriptional changes, given the 
recently reported interplay between Ca2+ influx and gene 
networks (Stancill et al. 2017). Third, ChR2 and eNpHR3.0 
significantly improved glucose tolerance in vivo without 
illumination (Reinbothe et al. 2014, Johnston et al. 2016), 
an effect that cannot be explained by their activity, as no 
illumination was present. Lastly, all optogenes introduce 
an exogenous photocurrent, and while no issues have been 
reported for ChR2, an increase in beta cell excitability was 
reported following inactivation of eNpHR3.0 (Johnston 
et al. 2016), probably due to a collapse in the Cl− gradient 
and depolarisation following a shift in the Cl− reversal 
potential (Raimondo et  al. 2012). Thus, as for RNA-seq, 
CyTOF and other techniques used in the study of beta 
cell heterogeneity, careful consideration of the datasets is 
required.
Beta cell heterogeneity – more questions 
raised than answered?
Beta cell heterogeneity is highly plastic in response to a 
pro-diabetic milieu. Thus, ST8SIA1+ beta cells increase 
in proportion in islets from T2DM donors (Dorrell et al. 
2016), similar to Fltp− beta cells that expand in number 
following metabolic stress (Bader et al. 2016). Hubs, as well 
as gap junction signalling, fail in the face of inflammation 
(Farnsworth et al. 2015, Johnston et al. 2016), while beta 
cell ion channel number is altered during T2DM (Dorrell 
et al. 2016, Wang et al. 2016b), and exocytosis is restricted 
to only a few beta cells in islets from obese db/db mice 
(Low et  al. 2014). However, the contribution of each 
event to T2DM and their inter-relations remain unclear. 
Are alterations in gap junction signalling preceded by 
subpopulation shifts to a more immature phenotype? If 
so, how can this be reconciled with the known molecular 
mechanisms underlying decreased gap junction coupling 
(i.e. protein kinase C delta) or evident heterogeneity in 
gap junction coupling strength (Farnsworth et al. 2015)? 
What is the overlap between the various subpopulations, 
given that mature Fltp+ and ST8SIA− cells both constitute 
~80% of the beta cell population? What are the relative 
dynamics of subpopulation shifts (e.g. from ST8SIA− -> 
ST8SIA1+) and how does this relate to changes in function 
and insulin release? Are these shifts permanent or can they 
be reversed following treatment of T2DM or remission in 
mouse models? Key to answering some of these questions 
will be technologies that allow heterogeneity to be 
longitudinally tracked with high temporal resolution.
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New tools for understanding beta 
cell heterogeneity
The majority of recent understanding concerning beta 
cell heterogeneity has been derived from ‘omics’ or high-
throughput approaches, such as RNA-seq and CyTOF. 
While these have identified subpopulations with similar 
characteristics in terms of maturity and insulin secretion, 
they have also highlighted differences in terms of the 
markers/genes that are differentially expressed. However, 
further description of heterogeneity will require the use 
of complementary techniques, as well as integration of 
the obtained datasets to increase detection sensitivity and 
accuracy.
Photopharmacology
Photopharmacology, otherwise referred to as 
optochemistry, describes the use of light to control the 
cell’s endogenous signalling apparatus/cytoskeleton 
(Velema et al. 2014). This approach relies on the synthesis of 
molecules whose inactive and active states can be precisely 
controlled by light. Central to photopharmacology, is 
the installation of photoresponsive elements, usually an 
azobenzene moiety, which undergoes isomerisation in 
response to illumination (a molecular motor) (Broichhagen 
et  al. 2015c) (Fig.  3A) (See 4 in Table  1). The ensuing 
shift between cis- and trans-isomers subtly influences 
molecular motion, altering binding conformations and 
thus placing ion channel, receptor and enzyme function 
under optical control (Broichhagen et al. 2015c). A major 
advantage of photopharmacology over optogenetics is the 
lack of requirement for recombinant engineering: drugs 
can be exogenously applied, for example, light-activated 
sulfonylureas (Broichhagen et al. 2014, 2015b), incretins 
(Broichhagen et al. 2015d, 2016) and GPR40 agonists (Frank 
et  al. 2017). Photopharmacology can serve as a tool to 
understand how GPCR or ion channel activation influences 
signalling and function in defined subpopulations, since 
these can feasibly be targeted with light as for hubs, with 
particular use in human islets. Pertinently, expression 
levels of Trpm6, and subunits for KATP and K+ channels 
all change in islets isolated from donors with T2DM 
(Dorrell et  al. 2016, Wang et  al. 2016b). However, there 
are disadvantages with photopharmacology: the lack of 
binary switch can complicate the optical control of cell 
function, UV illumination is generally required for the 
isomerisation step and toxicity and metabolite production 
need to be carefully assessed, just as for any drug, 
although the azobenzene itself appears to be well tolerated 
(Mehta et al. 2017).
Tethered pharmacology
Tethered pharmacology describes the production of small-
molecule and peptide agonists that are restricted to the 
cell surface or to a specific receptor through protein self-
labels (Leippe et  al. 2017, Shields et  al. 2017) (Fig.  3B) 
(See 5 in Table  1). Generally, this relies on covalent 
binding through SNAP tags, but can also take the form 
of engineered cysteines that react with maleimides 
introduced into the ligand (Leippe et  al. 2017, Shields 
et  al. 2017). Thus, tethered pharmacology allows cell 
signalling to be conditionally targeted, with the potential 
to further interrogate subpopulations using light-activated 
congeners, Cre-recombinase-directed expression of the 
SNAP-tag (Broichhagen et  al. 2015a, Levitz et  al. 2017) 
or even SNAP GPCR fusions, as recently shown for the 
GLP-1R in MIN6 beta cells (Podewin et al. 2018).
Single-cell metabolomics
While single-cell RNA and protein sequencing approaches 
provide valuable information regarding a cell’s potential, 
they are much less informative concerning dynamic 
responses to environment. By contrast, the metabolome 
gives a snapshot of metabolism by surveying the 
metabolites built up in a cell at a given time point (Johnson 
et al. 2016). Such an approach is clearly relevant for beta 
cells where oxidative and glycolytic metabolism underpin 
insulin release. However, investigating subpopulations 
is limited by the amount of tissue required for reliable 
metabolite measures, although metabolomics on FACS-
enriched populations from multiple islets (e.g. of Fltp−, 
ST8SIA1+ or Ucn3− cells) is plausible. Also, this does not 
take into account variability between single cells. Micro-
arrays for mass spectrometry have been applied to single 
yeast cells, revealing co-existing subpopulations in isogenic 
populations (Ibanez et al. 2013). Along similar lines, single 
neurons were subjected to capillary electrophoresis-mass 
spectrometry and metabolomic analysis using cytoplasm 
extracted under direct visualisation (Fig.  3C) (See 6 in 
Table 1) (Aerts et al. 2014). While this is slow throughput, 
3D holographic and tomographic laser microscopy 
coupled with a nanospray tip to extract picolitres of cytosol 
for mass spectroscopy may speed this up (Ali et al. 2016). 
Crucially, this circumvents the need to dissociate islets, 
meaning that metabolites can potentially be surveyed in 
situ in the whole islet.
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Figure 3
Future technologies for interrogating beta cell heterogeneity. (A) Photopharmacology uses light-activated drugs to turn receptors and ion channels into 
endogenous photoswitches. (B) Tethered pharmacology combines the precision of genetics with pharmacology to selectively target specific cell and 
receptor populations, and even organelles. (C) Single-cell metabolomics subjects cytoplasm extracted from specific cells to capillary electrophoresis-mass 
spectrometry, potentially delineating differences in metabolite abundances between subpopulations. (D) TIVA-tag affords optical control over mRNA 
capture in single cells using a photocleavable poly-U-oligo, which hybridises the corresponding poly-A-tail. (E) Two-photon imaging of islets transplanted 
into the anterior chamber of the eye allows beta cell heterogeneity to be visualised in a setting where vascular and neural supplies re-wire. Figures were 
adapted from Servier Medical Art under a CC-BY3.0 licence (https://creativecommons.org/licenses/by/3.0/).
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Transcriptome in vivo analysis
Endocrine cells display stable gene expression patterns in 
a tissue context, with this becoming pulsatile following 
dissociation (Featherstone et  al. 2011). Multiple rates of 
transcription can also be detected, with local coordination 
determined by gap junction communication (Featherstone 
et al. 2016). Such influence of the 3D architecture is likely 
to be lost following dissociation into single cells for high-
throughput analysis, meaning heterogeneity may not 
be fully captured. Moreover, the unique extracellular 
microenvironment present in vivo may exert another level 
of heterogeneity on gene expression (Michau et al. 2015, 
Arzouni et  al. 2017). Single-cell transcriptomes can be 
directly assessed in the tissue context directly in vitro and 
in vivo using transcriptome in vivo analysis (TIVA)-tags, 
which comprise a light-activated capture oligonucleotide 
that binds to the mRNA polyA tail, allowing affinity 
purification of TIVA-mRNA hybridised cells (Fig. 3D) (See 7 
in Table 1) (Lovatt et al. 2014). Using this technique, it was 
possible to show that the in vivo tissue microenvironment 
drives bimodal gene expression (27 vs 645 bimodal 
transcripts in single neurones from culture compared to 
in vivo, respectively) (Lovatt et al. 2014).
In vivo imaging
Little is known about in vivo function of beta cell 
subpopulations, other than static snapshots regarding 
their plasticity (e.g. proliferation of Fltp− cells or 
transdifferentiation of Ucn3− cells). The ability to study 
islets directly in vivo promises to provide novel information 
regarding the influence of the vascular or neural supplies 
on beta cell heterogeneity, whether heterogeneity 
contributes to insulin secretion in vivo and the dynamics 
of beta cell subpopulation plasticity (e.g. is it gradual or 
rapid? Do cells remain in a fixed state or interchange?). 
To facilitate such studies, rodent and human islets can be 
transplanted into the anterior chamber of the eye (Speier 
et  al. 2008a,b), which provides an optically translucent 
window into beta cell function when combined with 
epifluorescent, confocal or multiphoton imaging and even 
optogenetics (Fig. 3E) (See 8 in Table 1). Moreover, neurons 
and vascular supplies re-wire (Rodriguez-Diaz et al. 2012, 
Diez et al. 2017), affording the opportunity to investigate 
the influence of these on beta cell heterogeneity, and 
function/fate/plasticity can be followed longitudinally in 
the same animal (e.g. in response to high fat diet or anti-
diabetic drug therapy) (Abdulreda et  al. 2016, Paschen 
et  al. 2016). However, results need to be interpreted in 
light of some reported immune infiltration (Mojibian 
et al. 2013) and lack of endocrine–exocrine interactions. 
By contrast, imaging of the pancreas via abdominal 
laparotomy allows investigation of endocrine–exocrine 
interactions and native blood and neural supplies (Nyman 
et al. 2008, 2010, Michau et al. 2015), but is complicated 
due to movement and is restricted predominantly to 
surface islets in the splenic region.
Future challenges
Beta cell heterogeneity exists at many levels of islet 
operation, from genes > proteins > stimulus–secretion 
coupling > insulin release. High-throughput screening, as 
well as in situ imaging studies have provided unprecedented 
details regarding the molecular and cellular drivers of this 
heterogeneity, including subpopulations based upon their 
transcriptome, Ca2+ responses and secretory capacity. 
However, how heterogeneity co-exists at multiple levels 
is poorly described, in particular, the overlap between 
subpopulations. Moreover, as many subpopulations 
identified to date are defined by multiple markers or gene 
patterns, it remains difficult to functionally interrogate 
their contribution to islet function using conditional 
silencing or overexpression approaches. Technical and 
bioinformatic constraints also limit the sensitivity 
to delineate subpopulations, especially in islets from 
T2DM donors where despite best efforts to age, sex and 
BMI-match, variability can still stem from drug therapy, 
historic glycaemic control and timing of diagnosis. 
Indeed, validation of genes differentially expressed in 
three separate single-cell studies using islets from normal 
and T2DM donors, revealed overlap between 54/77 and 
32/171 significantly upregulated and downregulated 
genes, respectively (Lawlor et al. 2017). Nonetheless, this 
in itself demonstrates the power of combining RNA-seq 
results to finely resolve the transcriptome. We anticipate 
that the ever-increasing fidelity of single-cell technologies, 
the combination of functional and gene expression 
analysis and bioinformatics integration of datasets will 
expand the view of beta cell heterogeneity.
Going forwards, it will be important to demonstrate 
the relevance of heterogeneity for individuals with T2DM. 
Certainly, subpopulations with proliferative capacity could 
be harnessed to aid beta cell regeneration, although more 
detailed assessment of in situ functional heterogeneity is 
required in human islets to see if this reflects the available 
rodent data. Conversely, screens may identify drugs that 
protect susceptible subpopulations, preventing beta cell 
failure in the first place. The generation of beta cells from 
iPS cells should aim to recapitulate normal heterogeneity, 
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as changes in heterogeneity have consistently been shown 
to occur during T2DM, and in some cases, lead to lowered 
beta cell function. More broadly, the islet provides a 
tractable model for the study of heterogeneity in general, 
and results may be applicable to the study of other less 
accessible organs, for example, the pituitary gland where 
heterogeneity in at least two different axes has also been 
shown to be critical for proper hormone release (Sanchez-
Cardenas et al. 2010, Hodson et al. 2012, Le Tissier et al. 
2016).
Supplementary data
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